• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

David Einhorn Predicts Athenahealth’s Shares to Plummet 80% or More

by Fred Pennic 05/06/2014 1 Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
David Einhorn Predicts Athenahealth’s Shares to Fall
David Einhorn, President of Greenlight Capital, Inc

David Einhorn, President of hedge fund Greenlight Capital, Inc. poked fun at Athenahealth during this year’s Ira Sohn conference claiming the company is “overpriced and caught up in a bubble.” Einhorn noted that the stock could drop as much as 80 percent or more from its recent high in March of this year. The criticism comes after the company recently missed earning targets despite shares spiking earlier this year to the $200 mark in March. Since then shares have fallen considerably closing at $126.78 on Monday, Bloomberg reports (Summers, Bloomberg Businessweek, 5/5).

In his presentation on Monday to Wall Street’s elite investors, Einborn used various video interviews of Athenahealth’s CEO, Jonathan Bush as comedy stating the videos were full of “buzz words” to highlight that the company was not worth its valuation. Einhorn believes the company’s practice management/EHR and billing products are overvalued by investors who put cloud computing-like valuations on the company. “There will always be high-risk, low-margin things to do that will make healthcare better. Shareholders might want to consider the ramifications of the misallocation of capital.” Athena “isn’t positioned to succeed the way bulls hope,” Einhorn said.

“We believe there are serious risks to the business model mostly ignored by bullish investors and sell-side analysts,” he said. “The thing about bubble stocks is the best reason to own them is because they are going up. When they stop going up, these stocks become falling knives,” Einhorn added. Despite the harsh criticism and satire, Einhorn insists he’s not rooting for the company to fail (Britt , Marketwatch, 5/5).

Einhorn proclaimed Epic as the “undisputed winner” highlighting its recent partnership with CVS CareMark to use their EpicCare EHR system for their MinuteClinics. He referred to Epic as the “2,000 pound gorilla from Wisconsin”

Officials at Athenahealth could not be reached for comment.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low, But AI Dominates and $1B+ IPOs Emerge

Healthcare Investment Shifts in 1H 2025: AI Remains a Bright Spot Amidst Fundraising Decline

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low

Digital Health Faces Q2’25 Pullback: Funding Falls to 5-Year Low

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |